14th Jul 2016 08:14
LONDON (Alliance News) - OptiBiotix Health PLC said on Thursday it has filed a patent for ingredients thought to reduce the risk of heart disease.
The patent filing followed the finding of a strain of lactobacillus plantarum as a cholesterol-reducing supplement which, along with other ingredients, could reduce cardiovascular risk factors.
"We are pleased to announce the filing of this patent which adds a further level of protection and value to our cholesterol and blood pressure reducing product. Given the scale of the market opportunity in cardiovascular health and the limitations of existing products, combining our safe and efficacious product with existing treatments significantly broadens the commercial opportunity for OptiBiotix," said OptiBiotix Chief Executive Stephen O'Hara.
Shares in OptiBiotix were up 1.6% Thursday morning at 79.28 pence.
By Lucy Heming; [email protected]
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
OptiBiotix Health